Radioguided surgery for lymph node metastases in prostate cancer

Area of Science:

• Oncology
• Surgical Innovation
• Nuclear Medicine

Background:

• Prostate cancer management requires precise staging and treatment of metastatic disease.
• Radioguided surgery (RGS) offers potential for enhanced intraoperative guidance.
• Prostate-specific membrane antigen (PSMA) is a promising target for imaging and therapy in prostate cancer.

Purpose of the Study:

• To review recent advancements in PSMA-targeted radioguided surgery (RGS) for prostate cancer.
• To provide expert insights into current research and clinical implications.
• To discuss future directions in PSMA-RGS for prostate cancer.

Main Methods:

• Review of recent literature on PSMA-RGS in prostate cancer.
• Analysis of studies focusing on lymph node detection and metastatic lesion removal.
• Evaluation of novel PSMA ligands and integrated imaging techniques.

Main Results:

• PSMA-RGS demonstrates potential for improved detection of lymph node metastasis in primary prostate cancer.
• Successful removal of metastatic lesions in oligorecurrent prostate cancer patients is feasible with PSMA-RGS.
• Robot-assisted PSMA-RGS using miniaturized gamma probes is feasible.
• Novel PSMA ligands and fluorescence imaging integration show promise for enhanced guidance.

Conclusions:

• PSMA-RGS is an emerging technique with potential to improve lymph node assessment and treatment outcomes in prostate cancer.
• The impact of PSMA-RGS on cancer-specific and overall survival requires further investigation.
• PSMA-targeted surgery is an active area of ongoing research and development.